IMVT (STOCKS)
Immunovant, Inc. Common Stock
$41.716100
-0.883900 (-2.07%)
Prev close: $42.600000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Eric Venker
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $9,555.45M
- Employees
- 362
- P/E (TTM)
- -14.89
- P/B (TTM)
- 11.95
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
9
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q1)
|
$-0.75 | $-0.63 | -0.1223 | -19.48% |
|
Mar 2026 (Q4)
|
$-0.73 | $-0.61 | -0.1171 | -19.11% |
|
Dec 2025 (Q3)
|
$-0.61 | $-0.73 | +0.1185 | +16.27% |
|
Sep 2025 (Q2)
|
$-0.73 | $-0.73 | +0.0015 | +0.21% |